HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAB5. A total of 7 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $24,079,000 | +8.2% | 12,750,000 | 0.0% | 0.54% | +24.9% |
| Q1 2022 | $22,252,000 | -0.2% | 12,750,000 | 0.0% | 0.43% | -6.9% |
| Q4 2021 | $22,298,000 | +11.0% | 12,750,000 | +13.3% | 0.47% | +1.1% |
| Q3 2021 | $20,091,000 | -8.9% | 11,250,000 | 0.0% | 0.46% | -3.8% |
| Q2 2021 | $22,065,000 | +8.8% | 11,250,000 | +2.3% | 0.48% | -8.4% |
| Q1 2021 | $20,287,000 | – | 11,000,000 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |